Salary: Dependent on relevant Postdoctoral experience. Future progression is based on annual performance review. If the candidate has not yet been awarded their PhD, the starting salary will be at £35,844 until the successful completion of their viva.
This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here.
Duration of Contract: Fixed Term for 3 years
Hours per week: 35 hours per week (Full Time)
Closing Date: 29th November 2023
Interviews: 13th / 14th December 2023.
Under the leadership of Olivia Rossanese, we are seeking to appoint a Postdoctoral Training Fellow to join the Target Evaluation and Molecular Therapeutics (TEMT) team within the Division of Cancer Therapeutics.
For general information on Post Doc's at The ICR can be found here.
Applicants must have a PhD in cell biology, cancer biology, genetics, or similar. Experience in modern cell and molecular biology techniques is essential. Experience with -omics level profiling and handling of large datasets is desired. Excellent organisational and communication skills are also required.
The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 10 years.
The Target Evaluation and Molecular Therapeutics (TEMT) team, within the Division of Cancer Therapeutics, has a dual role in investigating the underlying biology of cancer targets and the response to targeted therapeutics and in developing assays and strategies to support drug discovery.
The Centre for Cancer Drug Discovery (CCDD), within the Division of Cancer Therapeutics (DCT), is a multidisciplinary 'bench to bedside' centre, comprising around 200 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The CCDD’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible. Our world-class biologists, chemists and drug metabolism specialists work together focusing on new molecular targets emerging from human genome and ground-breaking cell biology research. This is an exciting and fast-moving cancer research setup and offers the opportunity to work within a multi-disciplinary environment using state-of-the-art techniques and equipment.
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Olivia Rossanese via emailing [email protected]
Why work for us?
As a member of staff, you'll have exclusive access to a range of staff benefits.
The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.
The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.